Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 2
2007 3
2009 3
2010 5
2011 13
2012 16
2013 15
2014 20
2015 18
2016 15
2017 21
2018 20
2019 43
2020 46
2021 64
2022 64
2023 58
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
Expert consensus on the glycemic management of critically ill patients.
Wu Z, Liu J, Zhang D, Kang K, Zuo X, Xu Q, Pan A, Fang W, Liu F, Shang Y, Yin H, Hu J, Liu J, Fu J, Zhang W, Zong Y, Shao M, Zhao F, Meng M, Mao Y, Li Y, Chen D. Wu Z, et al. Among authors: kang k. J Intensive Med. 2022 Jul 8;2(3):131-145. doi: 10.1016/j.jointm.2022.06.001. eCollection 2022 Jul. J Intensive Med. 2022. PMID: 36789019 Free PMC article. No abstract available.
Long-Term Exposure to Fine Particulate Matter and Incidence of Esophageal Cancer: A Prospective Study of 0.5 Million Chinese Adults.
Sun D, Liu C, Zhu Y, Yu C, Guo Y, Sun D, Pang Y, Pei P, Du H, Yang L, Chen Y, Meng X, Liu Y, Zhang J, Schmidt D, Avery D, Chen J, Chen Z, Lv J, Kan H, Li L; China Kadoorie Biobank Collaborative Group. Sun D, et al. Gastroenterology. 2023 Jul;165(1):61-70.e5. doi: 10.1053/j.gastro.2023.03.233. Epub 2023 Apr 13. Gastroenterology. 2023. PMID: 37059339 Free PMC article.
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.
Zhou X, Zhou L, Yao Z, Huang M, Gong Y, Zou B, Zhu J, Liu Y, Peng F, Zhang Y, Yu M, Li Y, Na F, Wu Y, Kang K, Xiu W, Zhang X, Zhou L, Xu Y, Wang J, Wang Y, Yang X, Wu Y, Li R, Zhang Y, Yang Z, Zhou Z, Bai J, Yi X, Tong R, Yin L, Chen C, Niedermann G, Lu Y, Xue J. Zhou X, et al. Among authors: kang k. Clin Cancer Res. 2023 Oct 13;29(20):4098-4108. doi: 10.1158/1078-0432.CCR-23-0315. Clin Cancer Res. 2023. PMID: 37581611
413 results